A study of EVs in TAF from preterm infants born between 22 and 35 weeks of gestational age demonstrated that EVs from infants with a risk of BPD had increased surface proteins of CD24 and CD14 [110]. This evidence concerns the gene CD14 and bronchopulmonary dysplasia.